Faris Twal

Faris Twal, Pharm.D., is currently the Senior Director of Medical Affairs at Sarepta Therapeutics, specializing in rare disease RNA and gene therapy within the neuromuscular field since March 2019. Prior to this role, Faris served as the Director of Global Medical Affairs at the same company and held the position of Associate Director of Medical Affairs at MannKind Corporation. Previous experience includes roles as a Medical Science Liaison at QuintilesIMS and Clinical Science Specialist in Cardiovascular/Metabolic at Janssen Pharmaceuticals, where responsibilities involved providing scientific support to healthcare professionals. Further back, Faris was a Pharmacy Manager at CVS Health for nearly nine years, focusing on optimizing drug therapy and conducting Drug Utilization Reviews, and also managed compounding operations at Rph Investment. Faris holds a Doctor of Pharmacy from the Massachusetts College of Pharmacy and Health Sciences, Biotechnology from the University of Nebraska at Omaha, and is currently pursuing Health Economics training at the University of Arizona.